Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
Hanke CW, Narins RS, Brandt F, Cohen JL, Donofrio LM, Downie J, Heinz M, Harrington L, McDaniel DH, Nestor M, Schlessinger J, Schlöbe A, Taub A, Weiss RA. Hanke CW, et al. Among authors: mcdaniel dh. Dermatol Surg. 2013 Jun;39(6):891-9. doi: 10.1111/dsu.12160. Epub 2013 Mar 18. Dermatol Surg. 2013. PMID: 23506308 Clinical Trial.
54 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page